Skip to content
Recall Observatory FDA recall evidence

Drug product

Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-453-01.

D-1862-2019

September 06, 2019

Class II

Product summary

Firm
Torrent Pharma Inc.
Event
Event 83733
Status
Terminated
Classification
Class II
Quantity
2472 bottles
Official record key
drug-enforcement:D-1862-2019

Official wording

Reason: Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.

Code information: Lot #: BFE2E003, Exp 08/31/2020

Distribution pattern: Nationwide in the USA and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out Of Specification